Janssen-Cilag NE & MEWA fluently reports thanks to Aexis and Infor PM BPA

Janssen-Cilag NE & MEWA is part of Janssen-Cilag, a worldwide leading research-based pharmaceutical company, with over 20,000 employees. The company operates in almost every corner of Europe and has offices in 45 countries.  Janssen-Cilag develops prescription and prescription free medicines for a broad range of therapeutic areas such as pain, psychiatry, neurology, gastrointestinal and fungal diseases.
The company belongs to Johnson & Johnson, the world's most comprehensive and broadly based manufacturer of health care products.

After the reorganization of their international areas, the reporting process at Janssen-Cilag New Europe (NE) and Middle East/West Africa (MEWA) threatened to be strongly delayed. Because of this, the necessity to acquire an adapted solution for quick and efficient reporting became increasingly important.
Janssen-Cilag needed an application which would provide them, as well as their business partners, clear information about the available data. At the same time, it would enable them to react very quickly to changes.  Additional workload from IT was not to compromise the independence of the Finance department.
Aexis offered a solution with the Infor PM BPA application. Janssen-Cilag now has an integrated system which meets its requirements perfectly and leaves room to grow with the fast-changing business environment.